We are live on
!
Find out more
AC
Armistice Capital Portfolio holdings
AUM
$5.62B
1-Year Est. Return
36.06%
This Fund
S&P 500
This Quarter
Est. Return
+13.99%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$7.33B
AUM Growth
+$796M
(+12%)
Cap. Flow
-$12M
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
60.07%
Holding
377
New
123
Increased
61
Reduced
77
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$68.6M |
| 2 |
argenx
ARGX
|
+$55M |
| 3 |
Sanofi
SNY
|
+$50.7M |
| 4 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$50.5M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
+$42.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$48.6M |
| 2 |
Keurig Dr Pepper
KDP
|
+$45.5M |
| 3 |
Incyte
INCY
|
+$45.2M |
| 4 |
UnitedHealth
UNH
|
+$37.3M |
| 5 |
Campbell Soup
CPB
|
+$32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.97% |
| 2 | Consumer Staples | 5.35% |
| 3 | Consumer Discretionary | 4.92% |
| 4 | Technology | 3.86% |
| 5 | Communication Services | 1.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
T Stamp
IDAI
$16.9M
| $1.03M | 0.01% |
+50,267
| New | +$1.07M |
|
|
GOOS
177
Canada Goose Holdings
GOOS
$861M
| $1.01M | 0.01% |
+85,000
| New | +$1.01M |
|
|
BCTXW
178
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
| $938K | 0.01% |
375,000
| – | – |
|
179
SuperCom
SPCB
$67.3M
| $927K | 0.01% |
120,000
+86,950
| +263% | +$719K |
|
180
SELLAS Life Sciences
SLS
$2.33B
| $869K | 0.01% |
+820,000
| New | +$887K |
|
181
Conagra Brands
CAG
$7.18B
| $859K | 0.01% |
+29,969
| New | +$840K |
|
182
Momentus
MNTS
$79.9M
| $851K | 0.01% |
+1,969
| New | +$1.35M |
|
183
Flowers Foods
FLO
$1.57B
| $839K | 0.01% |
+37,274
| New | +$804K |
|
|
GAP
184
The Gap Inc
GAP
$7.4B
| $816K | 0.01% |
+39,006
| New | +$629K |
|
185
RH
RH
$3.7B
| $777K | 0.01% |
2,664
-16,871
| -86% | -$4.36M |
|
186
Dollar Tree
DLTR
$24.7B
| $751K | 0.01% |
+5,284
| New | +$626K |
|
187
Vivos Therapeutics
VVOS
$4.73M
| $709K | 0.01% |
+57,000
| New | +$489K |
|
188
Kroger
KR
$34.7B
| $681K | 0.01% |
14,895
+4,918
| +49% | +$218K |
|
|
BFX
189
DELISTED
BowFlex Inc.
BFX
| $662K | 0.01% |
860,000
-1,400,000
| -62% | -$953K |
|
190
Target
TGT
$67.1B
| $626K | 0.01% |
4,397
-113,828
| -96% | -$13.9M |
|
191
HubSpot
HUBS
$12.8B
| $621K | 0.01% |
+1,070
| New | +$515K |
|
192
Capri Holdings
CPRI
$1.84B
| $595K | 0.01% |
11,842
+4,399
| +59% | +$219K |
|
193
Mustang Bio
MBIO
$4.52M
| $588K | 0.01% |
+8,715
| New | +$692K |
|
194
GeoVax Labs
GOVX
$3.87M
| $587K | 0.01% |
+4,337
| New | +$759K |
|
|
SBFM
195
Sunshine Biopharma
SBFM
$3.16M
| $578K | 0.01% |
107
+58
| +118% | +$330K |
|
|
TRVN
196
DELISTED
Trevena, Inc.
TRVN
| $576K | 0.01% |
+31,909
| New | +$476K |
|
197
Newell Brands
NWL
$2.63B
| $570K | 0.01% |
+65,675
| New | +$501K |
|
|
MCW
198
DELISTED
Mister Car Wash
MCW
| $558K | 0.01% |
+64,628
| New | +$438K |
|
199
Logitech
LOGI
$15.1B
| $540K | 0.01% |
+5,682
| New | +$467K |
|
200
New York Times
NYT
$10.6B
| $510K | 0.01% |
+10,414
| New | +$459K |
|
Similar funds
CRC
RMDI
F
EW
O
DSC
ACM
PI
Armistice Capital's Q4 2023 Portfolio in Review
As of Q4 2023, Armistice Capital held 377 positions worth $7.33B, up 12% from $6.53B the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Armistice Capital's Q4 2023 filing shows 123 new, 61 increased, 77 reduced and 82 closed positions. Its largest new stake was Sanofi: 1,036,000 shares worth $51.5M. The largest sale was Mirati Therapeutics, Inc. Common Stock, an estimated $48.6M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 34% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
- Armistice Capital's largest Q4 2023 buy was Sanofi: 1,036,000 shares worth $51.5M.
- Armistice Capital added most to GSK in Q4 2023, an estimated $68.6M increase.
- Armistice Capital's biggest Q4 2023 reduction was Mirati Therapeutics, Inc. Common Stock, cutting an estimated $48.6M.
- Armistice Capital fully exited Keurig Dr Pepper in Q4 2023, selling an estimated $45.5M.
- Armistice Capital's ten largest holdings make up 60% of its $7.33B portfolio in Q4 2023.
- Armistice Capital opened 123 new positions and closed 82 in Q4 2023.
- Armistice Capital's portfolio value rose 12% quarter-over-quarter to $7.33B.
Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.